GlassScriptPhysician profile
Madeliene E Gainers
NPI 1679779565
$1,413.86
in general payments reported to CMS, 2019-2025
18 companies · $14.83 in 2025
The $14.83 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2021: $51.02 · 2022: $15.28 · 2023: $161 · 2024: $280 · 2025: $14.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.24 | 2019-2025 | |
| Pfizer INC. | $177.73 | 2019-2023 | |
| Janssen Biotech, INC. | $137.60 | 2019-2023 | Tremfya |
| Novartis Pharmaceuticals Corporation | $123.80 | 2019 | |
| Genzyme Corporation | $95.60 | 2019-2021 | |
| Galderma Laboratories, L.P. | $31.20 | 2019 | |
| Merz North America, INC. | $25.68 | 2019 | |
| Journey Medical Corporation | $23.36 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $20.91 | 2019 | |
| Arcutis Biotherapeutics, INC. | $19.77 | 2024 | Zoryve |
| Almirall LLC | $19.22 | 2019 | |
| Organogenesis INC. | $19.22 | 2021 | |
| Aclaris Therapeutics, INC. | $18.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.91 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.49 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.89 | 2019 | |
| Mission Pharmacal Company | $13.52 | 2019 | |
| Celgene Corporation | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeliene Gainers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.